JP2003513935A - マイコプラズマ・ボビスに対するワクチンおよび使用方法 - Google Patents

マイコプラズマ・ボビスに対するワクチンおよび使用方法

Info

Publication number
JP2003513935A
JP2003513935A JP2001536186A JP2001536186A JP2003513935A JP 2003513935 A JP2003513935 A JP 2003513935A JP 2001536186 A JP2001536186 A JP 2001536186A JP 2001536186 A JP2001536186 A JP 2001536186A JP 2003513935 A JP2003513935 A JP 2003513935A
Authority
JP
Japan
Prior art keywords
mycoplasma bovis
biotype
vaccine
mycoplasma
inactivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513935A5 (enExample
Inventor
ジョーン・ディ・レナード
ロバート・ダブリュー・タリー
Original Assignee
バイオミューン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオミューン filed Critical バイオミューン
Publication of JP2003513935A publication Critical patent/JP2003513935A/ja
Publication of JP2003513935A5 publication Critical patent/JP2003513935A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2001536186A 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法 Pending JP2003513935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
US60/164,286 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (2)

Publication Number Publication Date
JP2003513935A true JP2003513935A (ja) 2003-04-15
JP2003513935A5 JP2003513935A5 (enExample) 2007-12-27

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536186A Pending JP2003513935A (ja) 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法

Country Status (10)

Country Link
US (7) US7943153B1 (enExample)
EP (1) EP1229929A2 (enExample)
JP (1) JP2003513935A (enExample)
AU (1) AU782508B2 (enExample)
BR (1) BR0015398A (enExample)
CA (1) CA2390613A1 (enExample)
IL (1) IL149471A0 (enExample)
MX (1) MXPA02004627A (enExample)
WO (1) WO2001034189A2 (enExample)
ZA (1) ZA200203622B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507537A (ja) * 2008-10-31 2012-03-29 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド マイコプラズマ・ボビスの抗原を含む種々の抗原の多価ワクチン組成物における使用
KR20180074804A (ko) 2009-06-04 2018-07-03 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
BR0211563A (pt) * 2001-08-28 2004-07-13 Pfizer Prod Inc Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2011044576A2 (en) 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
EP2621951A1 (en) * 2010-09-29 2013-08-07 Université de Liège Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
CN116751723A (zh) * 2023-07-24 2023-09-15 吉林农业大学 一种牛支原体菌株及其灭活疫苗和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043272B1 (en) 1980-07-01 1984-06-13 National Research Development Corporation Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN5002020469, ＢＯＯＴＨＢＹ Ｊ Ｔ, ＣＡＮＡＤＩＡＮ ＪＯＵＲＮＡＬ ＯＦ ＶＥＴＥＲＩＮＡＲＹ ＲＥＳＥＡＲＣＨ, 198807, Ｖ５２Ｎ３, Ｐ３５５−３５９ *
JPN5002020470, ＨＯＷＡＲＤ Ｃ Ｊ, ＲＥＳＥＡＲＣＨ ＩＮ ＶＥＴＥＲＩＮＡＲＹ ＳＣＩＥＮＣＥ, 1979, Ｖ２８Ｎ２, Ｐ２４２−２４９ *
JPN7010003154, Ｖｅｔｅｒｉｎａｒｙ Ｍｉｃｒｏｂｉｏｌｏｇｙ, 1980, ５, ｐ．１１３−１２２ *
JPN7010003155, Ｖｅｔｅｒｉｎａｒｙ Ｒｅｃｏｒｄ, 1987, １２１, ｐ．３７２−３７６ *
JPN7010003156, Ｒ． Ｒｏｓｅｎｂｕｓｃｈ, Ｐｒｏｃ． １２ｔｈ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｏｒｇａｎｉｓａｔｉｏｎ ｏｆ Ｍｙｃｏｐｌａｓｍｏｌｏｇｙ Ｃｏｎｆｅｒｅｎｃｅ, 1998, ｐ．１８５ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507537A (ja) * 2008-10-31 2012-03-29 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド マイコプラズマ・ボビスの抗原を含む種々の抗原の多価ワクチン組成物における使用
KR20180074804A (ko) 2009-06-04 2018-07-03 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신

Also Published As

Publication number Publication date
US20090263427A1 (en) 2009-10-22
US20070077260A1 (en) 2007-04-05
US20050118200A1 (en) 2005-06-02
BR0015398A (pt) 2002-06-25
AU782508B2 (en) 2005-08-04
IL149471A0 (en) 2002-11-10
US7429389B2 (en) 2008-09-30
US20050053627A1 (en) 2005-03-10
US20080226671A1 (en) 2008-09-18
US20090220550A1 (en) 2009-09-03
AU2622501A (en) 2001-06-06
US7943153B1 (en) 2011-05-17
US20080069842A9 (en) 2008-03-20
US7416734B2 (en) 2008-08-26
WO2001034189A2 (en) 2001-05-17
CA2390613A1 (en) 2001-05-17
MXPA02004627A (es) 2004-02-18
WO2001034189A3 (en) 2001-12-27
ZA200203622B (en) 2003-07-30
EP1229929A2 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
US20090263427A1 (en) Vaccines for mycoplasma bovis and methods of use
EP2561063B1 (en) A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5
SK15792003A3 (sk) Použitie Mycoplasma hyopneumoniae na výrobu liečiva
CN101827605B (zh) 牛支原体疫苗
CN115243715B (zh) 保护以对抗血清型9、序列型16的猪链球菌的疫苗
US6585981B1 (en) Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
JP2012521391A (ja) 各種血清型のブタ連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｓｕｉｓ）細菌から防御するためのワクチン
UA121097C2 (uk) Імуногенна композиція, що містить антигени мікоплазм
JP3178720B2 (ja) パスツレラ・ムルトシダのトキソイドワクチン
RU2043771C1 (ru) Вакцина против эшерихиоза животных
KR101210082B1 (ko) 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법
US8563005B2 (en) Actinobacillus suis antigens
KR101209964B1 (ko) 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법
Walker Bacterial vaccines
Smith The Use of live cultures of Pasteurella haemolytica Pasteurella multocida to immunize cattle against bovine respiratory disease
Farley Studies on shipping fever
HK1134900B (en) One dose vaccination with (1) mycoplasma hyopneumoniae (/1)
AU2001277207A2 (en) Temperature-sensitive live vaccine for mycoplasma hyopneumoniae

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101012

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110112

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110119

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110214

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110221

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110705